Kenvue, the maker of Tylenol, in 2018 privately admitted the likelihood of an association between the drug in pregnancy and neurodevelopmental disorders, according to a report by the Daily Caller.
“The weight of the evidence is starting to feel heavy to me,” Rachel Weinstein, U.S. director of epidemiology for Janssen, the pharmaceutical arm of Johnson & Johnson, said in company documents obtained by the Daily Caller from the law firm Keller Postman LLC, which brought a class action lawsuit against Kenvue in the Federal District Court for the Southern District of New York.
“We are talking with Rachel Ochs-Ross, the neurologist in CNS [Central Nervous System] today. Originally it was to talk about biologic plausibility for benefiting acetaminophen, but now we’ve added the studies in prenatal exposure and neurodev outcome.”
Read more at Newsmax© 2025 Newsmax. All rights reserved.